FDA Links Topamax® to Birth Defects

FDA Links Topamax® to Birth Defects The U.S. Food and Drug Administration (FDA) links Topamax® to cleft lip and cleft palate. Houston, Texas (PRWEB) May 13, 2011 The U.S. Food and Drug Administration (FDA) notified healthcare professionals and patients of a link between Topamax® (topiramate) and birth defects on March 4, 2011. Moulton & Arney, a litigation firm, is sponsoring TopamaxCleftLipLawyer.com, an online resource that aims to provide useful information about the Topamax® birth defect risk. 'The evidence reported by the FDA establishes a very troubling conn
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories